Qassim National Hospital (QNH), a general private hospital in Al-Qassim Province, Kingdom of Saudi Arabia, is renowned for its commitment to patient safety and delivering the highest standards of medical care.
Established in 2010, QNH has become a leader in medical innovation and excellence, setting new standards for patient safety in the region, and providing specialised care across 34 medical specialities and subspecialties, with a capacity of 135 in-patient bed units.
Over time, QNH has sought to continuously enhance its medical services by ensuring it operates to the highest standards of quality and patient care. The hospital has secured national and international accreditations like CBAHI, JCI, CAP, AABB, and ACHC.
Its facilities include an ambulatory setting with outpatient departments (OPD Clinics), a comprehensive emergency department, specialised units for dialysis, intensive care for adults, pediatrics, and neonates. The hospital also supports general medical and surgical wards for both male and female patients, labour and delivery rooms, operating theatres, a cardiac catheterisation lab, and well-equipped in-patient and out-patient pharmacies.
Qassim National Hospital places patient safety at the heart of its mission, implementing rigorous safety protocols and advanced technology to ensure the safest and most effective care possible. The hospital integrates electronic medical records (EMR) systems to reduce errors, employs real-time patient monitoring, and uses sophisticated diagnostic tools for early detection and timely intervention. QNH’s safety framework extends beyond traditional care settings with specialised programmes in infection control, medication safety, and patient education initiatives. These measures have been instrumental in achieving a low incidence of preventable errors and hospital-acquired infections.
Accreditations
“For healthcare facilities, accreditation seeks to promote organisational change through an approach that values the level of progress achieved within a validated reference framework. The aim is to analyse the role played by accreditation through the experience perceived by health professionals during the process of self-assessment and external evaluation, taking into account three dimensions of analysis: focus on the patient, internal organisation and leadership, and impact on the clinical aspects of healthcare,” QNH told International Finance.
“Accreditation serves as the bedrock of trust and quality assurance across industries. Whether it’s the health care service we receive, the food we eat, the buildings we work in, or the technology we rely on, accredited bodies ensure that standards are not just met but consistently upheld. This invisible framework guarantees that products and services are safe, reliable, and of high quality,” it added.
QNH began its accreditation journey in 2017 by obtaining the Gold Seal from the Joint Commission. In 2018, it achieved national mandatory accreditation from CBAHI. The successful run continued with the addition of laboratory and blood bank accreditations, which were awarded by the College of American Pathologists (CAP) and the Association for the Advancement of Blood and Biotherapies (AABB) in 2022 and 2023, respectively. This progression underscores QNH’s commitment to providing the safest care possible.
Reaccreditation surveys for JCI and CBAHI took place in 2023 and 2024, yielding outstanding results. Earlier this year, the hospital received the ACHC accreditation. The reaccreditation surveys for AABB and CAP were also conducted, producing exceptional results. The robust accreditation journey guaranteed that patients receive care in an environment that meets thousands of international and national standards for safer healthcare delivery, while also ensuring that staff work in a physically and psychologically safe environment.